These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis. Tam DY; Vo TX; Wijeysundera HC; Dvir D; Friedrich JO; Fremes SE Catheter Cardiovasc Interv; 2018 Dec; 92(7):1404-1411. PubMed ID: 30024102 [TBL] [Abstract][Full Text] [Related]
25. Transcatheter aortic valve-in-valve treatment of degenerative stentless supra-annular Freedom Solo valves: A single centre experience. Cockburn J; Dooley M; Parker J; Hill A; Hutchinson N; de Belder A; Trivedi U; Hildick-Smith D Catheter Cardiovasc Interv; 2017 Feb; 89(3):438-444. PubMed ID: 27315455 [TBL] [Abstract][Full Text] [Related]
26. Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement. Nelson BC; Chadderdon S; Song H; Zahr FE Catheter Cardiovasc Interv; 2019 Jan; 93(1):164-168. PubMed ID: 30298684 [TBL] [Abstract][Full Text] [Related]
27. Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves. AlBadri A; Joseph J; Patel V; Patel D; Koren O; Cheng W; Jilaihawi H; Makkar R JACC Cardiovasc Interv; 2023 Mar; 16(5):542-554. PubMed ID: 36922040 [TBL] [Abstract][Full Text] [Related]
28. Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human. Khan JM; Dvir D; Greenbaum AB; Babaliaros VC; Rogers T; Aldea G; Reisman M; Mackensen GB; Eng MHK; Paone G; Wang DD; Guyton RA; Devireddy CM; Schenke WH; Lederman RJ JACC Cardiovasc Interv; 2018 Apr; 11(7):677-689. PubMed ID: 29622147 [TBL] [Abstract][Full Text] [Related]
29. Sutureless and Transcatheter Aortic Valve Replacement: When Rivals Become Allies. Ellouze M; Mazine A; Carrier M; Bouchard D Semin Thorac Cardiovasc Surg; 2020 Autumn; 32(3):427-430. PubMed ID: 31330180 [TBL] [Abstract][Full Text] [Related]
31. A Tale of Two Polymers: Bioprosthetic Valve Remodeling Versus Bioprosthetic Valve Fracture of Mosaic Surgical Valves to Facilitate VIV TAVR. Chhatriwalla AK; Allen KB; Hu TX; Saxon JT; Huded CP; Hart AJ; Grier EA; Makkar R; Jilaihawi H; Greenbaum AB; Babaliaros VC; Whisenant BK; Yakubov SJ Circ Cardiovasc Interv; 2024 Jul; 17(7):e014276. PubMed ID: 38946556 [No Abstract] [Full Text] [Related]
32. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. Sawaya FJ; Deutsch MA; Seiffert M; Yoon SH; Codner P; Wickramarachchi U; Latib A; Petronio AS; Rodés-Cabau J; Taramasso M; Spaziano M; Bosmans J; Biasco L; Mylotte D; Savontaus M; Gheeraert P; Chan J; Jørgensen TH; Sievert H; Mocetti M; Lefèvre T; Maisano F; Mangieri A; Hildick-Smith D; Kornowski R; Makkar R; Bleiziffer S; Søndergaard L; De Backer O JACC Cardiovasc Interv; 2017 May; 10(10):1048-1056. PubMed ID: 28521923 [TBL] [Abstract][Full Text] [Related]
33. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction. Ye J; Lee AJ; Blanke P; Webb J Catheter Cardiovasc Interv; 2018 Nov; 92(6):1209-1214. PubMed ID: 29602249 [TBL] [Abstract][Full Text] [Related]
34. Surgical Complexity and Outcome of Patients Undergoing Re-do Aortic Valve Surgery. Greco R; Muretti M; Djordjevic J; Jin XY; Hill E; Renna M; Petrou M Open Heart; 2020; 7(1):e001209. PubMed ID: 32201590 [TBL] [Abstract][Full Text] [Related]
35. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve. Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659 [TBL] [Abstract][Full Text] [Related]
36. TAVR for Failed Surgical Aortic Bioprostheses Using a Self-Expanding Device: 1-Year Results From the Prospective VIVA Postmarket Study. Tchétché D; Chevalier B; Holzhey D; Harnath A; Schäfer U; Teiger E; Manigold T; Modine T; Souteyrand G; Champagnac D; Oh JK; Li S; Verhoye JP; Kornowski R; JACC Cardiovasc Interv; 2019 May; 12(10):923-932. PubMed ID: 31122349 [TBL] [Abstract][Full Text] [Related]
37. Transcatheter ViV Versus Redo Surgical AVR for the Management of Failed Biological Prosthesis: Early and Late Outcomes in a Propensity-Matched Cohort. Tam DY; Dharma C; Rocha RV; Ouzounian M; Wijeysundera HC; Austin PC; Chikwe J; Gaudino M; Fremes SE JACC Cardiovasc Interv; 2020 Mar; 13(6):765-774. PubMed ID: 31954671 [TBL] [Abstract][Full Text] [Related]
38. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202 [TBL] [Abstract][Full Text] [Related]
39. Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry. Forrest JK; Kaple RK; Tang GHL; Yakubov SJ; Nazif TM; Williams MR; Zhang A; Popma JJ; Reardon MJ JACC Cardiovasc Interv; 2020 Jan; 13(2):170-179. PubMed ID: 31973793 [TBL] [Abstract][Full Text] [Related]